Green ammonia, produced from renewable energy, is an excellent fuel and fertilizer that can potentially replace significant volumes of fossil fuels and help accelerate the transition to a world powered by renewable energy. A partnership of industry leaders now announces an ambition to realize this potential as soon as in 2022 with the world’s first green ammonia plant at the commercial scale of 10 MW power.
As HRH The Crown Prince of Denmark cuts the ribbon to inaugurate the new biomass based block at the Asnæs Power Station, all energy to Novozymes in Kalundborg comes from other sources than oil and coal.
Novozymes inaugurated its new Innovation Campus in Lyngby, 13 kilometers north of Copenhagen and seven kilometers from its headquarters in Bagsværd. With the location near the Technical University of Denmark, it is Novozymes’ ambition to create a global hub for biotech research.
The Danish Minister for Environment and Food, Esben Lunde Larsen, launched yesterday the white paper on Danish circular economy at the conference ‘Danish Pioneers of Sustainability’ hosted by the Conferederation of Danish Industry.
“By having the first full scale 2G biorefinery (Mossi & Ghisolfi’s Biorefinery in Crescentino, editor’s note) I am convinced that Italy will play one of the important and leading roles in 2G bioeconomy on a European level. We hope very much that the next full scale plant will be in Denmark.The EU countries have a unique chance to be first movers and preferred partners in the future global bioeconomy”. To say it, in this interview, is Anne Grete Holmsgaard, the director of the BioRefining Alliance, the Danish partnership organization working to promote 2G biofuels and bioeconomy in Europe. Denmark has a leading role in the European bioeconomy. With Anne Grete Holmsgaard we talk about BioRefining Alliance, but especially bioeconomy and European policies to foster it. “We need – says the BioRefining Alliance’s director – the EU to speed up and decide on a better regulation with targets for 2G biofuels, which will give a very clear signal to investors.
Interview by Mario Bonaccorso
IL BIOECONOMISTA 